| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/09/1995 | WO1995003801A1 Antidepressant |
| 02/09/1995 | WO1995003800A1 Non-racemic compositions of spirofluorenehydantoins |
| 02/09/1995 | WO1995003799A1 Use of benzydamine in the treatment of pathological conditions caused by tnf |
| 02/09/1995 | WO1995003798A2 USE OF CENTRALLY EFFECTIVE α-2 AGONISTS FOR INHIBITING POSTAGGRESSION METABOLISM |
| 02/09/1995 | WO1995003797A1 Method to inhibit restenosis |
| 02/09/1995 | WO1995003796A1 New combination of active substances containing esupron and levodopa |
| 02/09/1995 | WO1995003795A1 Method of treating atherosclerosis or restenosis using microtubule stabilizing agent |
| 02/09/1995 | WO1995003794A1 3-cyano-3-(3,4-disubstituted)phenylcyclohexyl-1-carboxylates |
| 02/09/1995 | WO1995003793A1 Use of n-methyl-aspartic acid for enhancing growth and altering body composition |
| 02/09/1995 | WO1995003792A1 Use of thiol compounds in the therapy of viral diseases |
| 02/09/1995 | WO1995003791A1 Stabilized pharmaceutical composition containing bupropion |
| 02/09/1995 | WO1995003788A1 Liposomal antisense methyl phosphonate oligonucleotides and methods for their preparation and use |
| 02/09/1995 | WO1995003786A2 New pharmaceutical compositions for topical use containing hyaluronic acid and its derivatives |
| 02/09/1995 | WO1995003775A1 Antifungal nail solution |
| 02/09/1995 | WO1995003764A1 Skin patches and methods for providing testosterone |
| 02/09/1995 | WO1995003753A1 Medicinal for protection from neurological damage |
| 02/09/1995 | WO1995003701A1 Jak kinases and regulation of cytokine signal transduction |
| 02/09/1995 | WO1994022437A3 Method for treating amyloidosis |
| 02/09/1995 | DE4428025A1 Inhibitoren der Acyl-Enzym-A-Cholesterin-O-Acyl-Transferase mit therapeutischer Wirksamkeit, ihre Verwendung und sie enthaltende pharmazeutische Zusammensetzungen Inhibitors of acyl-enzyme A: cholesterol O-acyl transferase with therapeutic efficacy, their use and pharmaceutical compositions containing them |
| 02/09/1995 | DE4325900A1 Trisubstituted pyrimido[5,4-d]pyrimidines for the modulation of multi-drug resistance, medicaments containing these compounds and processes for their production |
| 02/09/1995 | DE4316724A1 Composition for the treatment of inflammatory disorders of the lower colon with 4-aminosalicylic acid as active ingredient |
| 02/09/1995 | CA2168886A1 A method for preparing and selecting pharmaceutically useful non-peptide compounds from a structurally diverse universal library |
| 02/09/1995 | CA2168657A1 15,15-dialkyl-substituted derivatives of estradiol |
| 02/09/1995 | CA2168463A1 Novel benzothiophene analogs as antiviral agents |
| 02/09/1995 | CA2168443A1 Piperazine derivatives as .alpha.1a-adrenergic receptor antagonists |
| 02/09/1995 | CA2168349A1 Intracellular immunization |
| 02/09/1995 | CA2168262A1 Methods of enhancing opiate analgesic potency or detoxifying an opiate addict |
| 02/09/1995 | CA2168257A1 Aminoindanes and related compounds useful as calcium-channel antagonists |
| 02/09/1995 | CA2168252A1 Thiazole derivatives as lipoxygenase inhibitors |
| 02/09/1995 | CA2168243A1 Liposomal antisense methyl phosphonate oligonucleotides and methods for their preparation and use |
| 02/09/1995 | CA2168233A1 Perhydroisoindole derivatives as substance p antagonists |
| 02/09/1995 | CA2168231A1 (thio)carbimidinic acid derivatives and pharmaceutical agents containing them |
| 02/09/1995 | CA2168099A1 Benzoxazinones and benzothiazinones endowed with therapeutic activity |
| 02/09/1995 | CA2168098A1 Jak kinases and regulation of cytokine signal transduction |
| 02/09/1995 | CA2168043A1 Method to inhibit restenosis |
| 02/09/1995 | CA2167818A1 Therapeutic compound - fatty acid conjugates |
| 02/09/1995 | CA2167680A1 Antisense oligonucleotide inhibition of vascular endothelial growth factor expression |
| 02/09/1995 | CA2167671A1 Processes and intermediates for phosphorous-containing covalent linkages |
| 02/09/1995 | CA2167480A1 Improvements relating to prodrugs |
| 02/09/1995 | CA2167411A1 4-phenyl-4-phenylpropyl(enyl)-piperidines as tachykinin antagonists |
| 02/09/1995 | CA2166892A1 Activated macrolactams having immunomodulatory activities |
| 02/09/1995 | CA2153236A1 Compounds having selective activity for retinoid x receptors, and means for modulation of processes mediated by retinoid x receptors |
| 02/09/1995 | CA2144729A1 Aqueous composition |
| 02/09/1995 | CA2144330A1 A therapeutic agent for parkinson's disease |
| 02/08/1995 | EP0637587A1 Bicyclic beta-lactam/paraben complexes |
| 02/08/1995 | EP0637586A1 2-(Piperidin-4-yl, pyridin-4-yl and tetrahydropyridin-4-yl)benzofuran-7-ol and carbamate derivatives, their preparation and their use as acetylcholinesterase inhibitors |
| 02/08/1995 | EP0637583A1 1-Aryloxy-3-alkylamino-2-propanol nitrate esters, the use thereof and corresponding pharmaceutical composition |
| 02/08/1995 | EP0637450A2 Composition for revitalizing scar tissue |
| 02/08/1995 | EP0637449A1 Use of L-carnitine or acyl L-carnitines and valproate for treating seizure disorders |
| 02/08/1995 | EP0637448A1 Combinations of glycinamide or N-acetylglycinamide with analgesic compounds |
| 02/08/1995 | EP0637447A2 Orally administrable cholesterol lowering agent |
| 02/08/1995 | EP0637316A1 Antisense oligonucleotide inhibition of papillomavirus |
| 02/08/1995 | EP0637315A1 Adenosine derivatives having a 2? agonist activity |
| 02/08/1995 | EP0637310A1 Water-soluble retinoids |
| 02/08/1995 | EP0637308A1 Benzodiazepine derivatives, compositions containing them and their use in therapy |
| 02/08/1995 | EP0637307A1 Imidazole, triazole and tetrazole derivatives |
| 02/08/1995 | EP0637306A1 4-imidomethyl-1- 2'phenyl-2'oxoethyl-] piperidines as serotonin 5ht 2?-antagonists, their preparation and use in therapy |
| 02/08/1995 | EP0637304A1 1-piperazineacetic derivatives as fibrinogen receptor antagonists |
| 02/08/1995 | EP0637303A1 N-aryloxy(thio)alkyl-azacycloalkanes useful as calcium channel antagonists |
| 02/08/1995 | EP0637300A1 Antiproliferative quinazolines |
| 02/08/1995 | EP0637299A1 20-methyl-substituted vitamin d derivates. |
| 02/08/1995 | EP0637297A1 Compounds having selectivity for retinoid x receptors |
| 02/08/1995 | EP0637245A1 Preparations of low molecular weight hyaluronic acid for stimulating bone formation |
| 02/08/1995 | EP0637244A1 A STRAIN OF $i(STREPTOMYCES AVERMITILIS) GLYCOSYLATES AVERMECTIN COMPOUNDS |
| 02/08/1995 | EP0637242A1 Agents for treating substance abuse disorders |
| 02/08/1995 | EP0637241A1 Synergistic combination of a substance with gastric acid secretion inhibiting effect and an acid degradable antibiotic |
| 02/08/1995 | EP0637240A1 Pharmaceutical compositions containing 3 and 4-substituted 2(5h)-furanones for inhibiting bone loss |
| 02/08/1995 | EP0637239A1 Method of promoting nitrogen retention in humans |
| 02/08/1995 | EP0637238A1 Treatment of macular degeneration |
| 02/08/1995 | EP0637237A1 Calcium receptor-active molecules |
| 02/08/1995 | EP0637203A1 Regulation of the immune system |
| 02/08/1995 | EP0560900B1 Prevention of synovial adhesions |
| 02/08/1995 | EP0174981B1 Method of treating depression in vertebrates |
| 02/08/1995 | CN1098414A Novel triazolopyrimidones, their preparation and use |
| 02/08/1995 | CN1098413A Xanthene derivant |
| 02/08/1995 | CN1098411A Oxazolidinedione derivatives, their production and use |
| 02/08/1995 | CN1098408A Heterocyclic inhibitors of farnesyl protein transferase |
| 02/08/1995 | CN1098407A Inhibitors of HIV protease useful for the treatment of aids |
| 02/08/1995 | CN1098406A New benzamide derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same |
| 02/08/1995 | CN1098404A Inhibitors of HIV protease useful for the treatment of aids |
| 02/08/1995 | CN1098288A Pharmaceutical composition |
| 02/08/1995 | CN1098287A Texiaoling fish medicine |
| 02/08/1995 | CN1098252A Solid storage stable germicidal pre-iodine composition |
| 02/08/1995 | CN1027588C Process for the preparation of N-phenylalkyl substituted alpha-amino carboxamide derivatives |
| 02/08/1995 | CN1027574C Method for preparation of injection for curing haemorrhoids |
| 02/07/1995 | US5387748 Antimicrobial dithiocarbamoyl quinolones |
| 02/07/1995 | US5387710 Ethanolamine derivatives having sympathomimetic and anti-pollakiuria activities |
| 02/07/1995 | US5387709 Bronchodilator agents, anticoagulants, vasodilation |
| 02/07/1995 | US5387685 Bicyclic amines; resensitize multiple drug resistant cells to chemotherapeutic agents |
| 02/07/1995 | US5387680 Immunosuppressants; useful to treat transplant rejection and autoimmune disorders |
| 02/07/1995 | US5387615 L-deprenyl for treating immune system dysfunction and compositions for same |
| 02/07/1995 | US5387614 Use of sigma receptor ligands as salivary gland stimulants |
| 02/07/1995 | US5387613 Administering propranolol |
| 02/07/1995 | US5387612 Administering title compound or salt; memory disorders |
| 02/07/1995 | US5387611 Use of butylurea, nonoxynol-9 and benzalkonium chloride as anti-bacterial, anti-viral contraceptive agents |
| 02/07/1995 | US5387609 Inhibiting ornithine decarboxylase activity |
| 02/07/1995 | US5387608 Ocular hypotensive agents for treatment of glaucoma; smooth muscle relaxants |
| 02/07/1995 | US5387606 Pharmaceutical compositions and method for administering 3 and 4-substituted 2(5H)-furanones to a mammal for inhibiting bone loss |
| 02/07/1995 | US5387604 Useful in treatment of anxiety, depression, migraine, stroke and hypertension |
| 02/07/1995 | US5387603 1,5,7-trisubstituted indoline compounds and salts thereof |